Literature DB >> 10476213

The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium.

C Kitson1, B Angel, D Judd, S Rothery, N J Severs, A Dewar, L Huang, S C Wadsworth, S H Cheng, D M Geddes, E W Alton.   

Abstract

Gene transfer to the respiratory epithelium is currently suboptimal and may be helped by the identification of limiting biological barriers. We have, therefore, developed an ex vivo model which retains many of the characteristics of in vivo native airways including mucociliary clearance, mucus coverage and an intact cellular structure. Using this model we have demonstrated several barriers to gene transfer. Liposome-mediated gene transfer was inhibited by normal mucus, with removal of this layer increasing expression approximately 25-fold. In addition both liposome and adenovirus were inhibited by CF sputum. The apical membrane represented a significant barrier to both agents. Adenovirus-mediated expression could be significantly augmented by increasing contact time or by pre-treatment of tissues with a nominally calcium-free medium. The presence of these extracellular and plasma membrane barriers appeared to be the key parameters responsible for the approximately three log difference in gene expression found in vitro compared with our ex vivo model. Cytoskeletal elements and the cell cycle also influenced in vitro gene transfer, and represent further barriers which need to be overcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476213     DOI: 10.1038/sj.gt.3300840

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  23 in total

1.  Mechanistic studies on nonviral gene delivery to the intestine using in vitro differentiated cell culture models and an in vivo rat intestinal loop.

Authors:  Sally-Ann Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

Review 2.  New therapeutic approaches for cystic fibrosis lung disease.

Authors:  Jane C Davies
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 3.  The potential for stem cell therapy in cystic fibrosis.

Authors:  Helen Spencer; Adam Jaffe
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

Review 4.  Gene therapy for children with cystic fibrosis--who has the right to choose?

Authors:  A Jaffé; S A Prasad; V Larcher; S Hart
Journal:  J Med Ethics       Date:  2006-06       Impact factor: 2.903

5.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

6.  Cell targeting in anti-cancer gene therapy.

Authors:  Mohd Azmi Mohd Lila; John Shia Kwong Siew; Hayati Zakaria; Suria Mohd Saad; Lim Shen Ni; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2004-01

7.  The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.

Authors:  Jung Soo Suk; Samuel K Lai; Ying-Ying Wang; Laura M Ensign; Pamela L Zeitlin; Michael P Boyle; Justin Hanes
Journal:  Biomaterials       Date:  2009-01-26       Impact factor: 12.479

Review 8.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

9.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

10.  An ovine tracheal explant culture model for allergic airway inflammation.

Authors:  Latasha Abeynaike; Els Nt Meeusen; Robert J Bischof
Journal:  J Inflamm (Lond)       Date:  2010-08-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.